Wallenberg Centre for Molecular Medicine

WCMM LiU

The Wallenberg Centre for Molecular Medicine (WCMM) at Linköping University is part of a national plan for Sweden to gain an internationally leading position in medical research.

WCMM at Linköping University (LiU) was created in 2015 as a joint effort between Knut and Alice Wallenberg Foundation, Linköping University and Health care institutions constituting Region Östergötland. The aim of our center is to explore the interface between medicine and technology, an area with large potential for in modern health care. The collaboration between researchers at the Faculty of Science and Engineering and the Faculty of Medicine and Health Sciences as well as at Linköping University Hospital has already resulted in established collaborations in the areas of imaging-diagnostics, bio-engineering and bio-materials. Thanks to the WCMM effort, we have now been able to recruit 13 new research groups from leading institutions world-wide to join our efforts in Linköping and Norrköping.

The researchers active in our center has extensive collaborations with investigators from the WCMM nodes in Gothenburg, Lund and Umeå as well as SciLife laboratories in Stockholm. These interactions are supported by the Program for Academic Leaders in Life Science (PALS), an initiative funded by Knut and Alice Wallenberg Foundation with the aim to increase nationwide interactions between research environments in Sweden.

Seminars and events

News

Woman looking up from working at her computer.

New research centre meets challenge of longer working lives

More and more people are working later into their lives – but what happens when health fails and this leads to sick leave? A new research centre at LiU is to find solutions for returning to work later in life and for a sustainable working life.

The shape of the cell nucleus influences cancer treatment

Cancer cells with a cell nucleus that is easily deformed are more sensitive to drugs that damage DNA, shows a new study. The results may also explain why combining certain cancer drugs can produce the opposite of the intended effect.

WCMM group member meeting 2025

A Milestone for Collaboration and Career Growth: The First National WCMM Group Member Meeting

On 16–17 October 2025, 130 group members from the four Wallenberg Centres for Molecular Medicine (WCMM) Gothenburg, Linköping, Lund, and Umeå, gathered in Stockholm for the first-ever national WCMM Group Member Meeting.

Five New Clinical Fellows Associated with WCMM in Linköping

WCMM at LiU is strengthening its clinical research environment by associating five new clinical fellows with the centre. These researchers, active in various medical specialties, will contribute valuable expertise and new perspectives to WCMM’s work.

Female researcher working with cells in a lab.

New discovery reveals how chromosome ends can be protected

Researchers have uncovered a previously unknown mechanism that safeguards the chromosome ends from being mistakenly repaired by the cell - a mistake with potentially catastrophic outcomes.

Demonstration of MR elastography.

Fatty liver – but not liver damage – common in type 2 diabetes

Six out of ten people with type 2 diabetes had fatty liver in a new study. Of these, only a small percentage had developed more severe liver disease. Type 2 diabetes in combination with obesity is linked to a greater risk.

WCMM are looking for postdocs

WCMM Networks in Sweden

The Wallenberg Centres for Molecular Medicine are key elements in a national effort to reposition Sweden as a world-leading life science nation.

The initiative was taken by the Knut and Alice Wallenberg Foundation, and is a joint venture with the Universities and University Hospitals of Gothenburg, Lund, Umeå and Linköping. SciLifeLab in Stockholm and Uppsala serves as a research partner and unique core facility for the four Centres.


Umeå
Lund
Gothenburg
SciLifeLab
Knut and Alice Wallenberg Foundation
Program for Academic Leaders in Life Science